Mathai Mammen, who until recently led research at Johnson & Johnson, will become...
The U.S.'s usual, reactive approach to disease — wait for it to spring up before...
Is there $21 billion left for Covid response, or $5 billion? The White House’s f...
Lisa Barnes runs one of the nation’s largest studies of Alzheimer’s disease focu...
In a rare move, the Dutch health ministry refused to provide coverage for a Gile...
The NIH has released data showing more clinical trial sponsors are reporting res...
Just three lupus drugs have been approved by the FDA in six decades. A new partn...
The Marburg outbreak in Equatorial Guinea continues to grow, the WHO said, as th...
New research from a CRISPR pioneer offers a potential solution to delivery chall...
In the first two months of this year, 15% of 16,000 Ozempic dispenses in British...
The FDA on Wednesday approved selling naloxone without a prescription, setting t...
Drugs that combat obesity could for the first time be included on the World Heal...
Hidden in this year’s federal spending bill lies a little-noticed change with bi...
The German biotech company announces its vaccine pipeline outlook, with infectio...
The argenx spinoff announced plans to further develop the antibody along with a ...
The obesity market is expected to grow at a compound annual growth rate (CAGR) o...
